Continence Aids Payment Scheme Variation 2011 (No. 2) (Cth)
Continence Aids Payment Scheme Variation 2011 (No.2)1
National Health Act 1953
I, MARK BUTLER, Minister for Mental Health and Ageing, make this Instrument under section 12 of the National Health Act 1953.
Dated 9th February 2011
MARK BUTLER
Minister for Mental Health and Ageing
1 Name of Instrument
This Instrument is the Continence Aids Payment Scheme Variation 2011 (No.2).
2 Commencement
This Instrument commences on the day after it is registered.
3 Variation of Continence Aids Payment Scheme 2010
Schedule 1 varies the Continence Aids Payment Scheme 2010.
Schedule 1 Variations
(section 3)
[1] Subsection 4(1), except the note
substitute
(1) The eligibility criteria for a person to participate in this Scheme are that the person:
(a) suffers from permanent and severe incontinence:
(i) caused by an eligible neurological condition; or
(ii) caused by an eligible other condition and the person has a Centrelink Pensioner Concession Card or entitlement, whether as a primary cardholder or a dependant of a cardholder; or
(iii) caused by an eligible other condition and the person has a Department of Veterans’ Affairs Pensioner Concession Card or entitlement, whether as a primary cardholder or a dependant of a cardholder; and
(b) is an Australian citizen or permanent resident within the meaning of those terms in the Australian Citizenship Act 2007; and
(c) is not ineligible because of subsection (2).
[2] After subsection 4(2)
insert
(3) For a person who:
(a) is eligible to participate in this Scheme under subparagraph 4(1)(a)(iii); and
(b) meets the other eligibility criteria for participation in this Scheme; and
(c) applied to participate in this Scheme between 1 July 2010 and the commencement of the Continence Aids Payment Scheme Variation 2011 (No.2);
the CAPS payment is the amount calculated in accordance with section 9 with effect from the date of application.
(4) Subsection (3) applies, even if the person’s application was rejected, provided that the person would have been eligible to participate in this Scheme if subparagraph 4(1)(a)(iii) had been in effect at that time.
[3] Schedule
Substitute
Part 1 – Eligible neurological condition
Category 1 SPINA BIFIDA and SYRINGOMYELIA
Arnold-Chiari Syndrome
Arthrogryposis
Caudal Regression Syndrome
Developmental Cord Disorder
Holoprosencephaly
Malformation of Spinal Cord
Sacral Agenesis
Spinal Agenesis
Spinal Cord Congenital Abnormality
Spinal Dysraphism
Spinal Hemangioma
Vater Syndrome/Vacterl Syndrome
Category 2 CEREBRAL PALSY
Dystonic Cerebral Palsy
Hereditary Spastic Paralysis
Spastic Quadriplegia
Category 3 INTELLECTUAL DISABILITY
2-Hydroxyglutaric Aciduria
Agenesis of Corpus Callosum
Alpers Disease
Angelman Syndrome
Apert Syndrome
ATRX Syndrome
Bardot Biedl Syndrome
Batten Disease
Beare-Stevenson Syndrome
Cats Cry Syndrome/Cri Du Chat Syndrome
CDKL5 Gene Mutation
Cerebral Migration Disorders
Charge Syndrome
Chime Syndrome
Chromosomal Abnormalities/Disorders
Chromosome 1 Deletion
Chromosome 13q Deletion Syndrome
Chromosome 15q Duplication Syndrome
Chromosome 18q Deletion Syndrome
Chromosome 1p36 Deletion Syndrome/Mono 1p36
Chromosome 22 Ring
Chromosome 2q Deletion Syndrome
Chromosome 6 Ring Syndrome
Chromosome 8 Abnormality
Chromosome 9p Deletion Syndrome
Chromosome 9q Deletion Syndrome
Chromosome Xp Duplication
Cockayne Syndrome
Coffin-Lowry Syndrome
Cognitive Impairment
Cohen Syndrome
Congenital Hydrocephalus
Congenital Neurological Infections
Cornelia de Lange Syndrome
Costello Syndrome
Cowden Disease
Developmental Delay
Developmental Delay associated with Autism, Autism Spectrum Disorder and Aspergers Syndrome
Down Syndrome/Trisomy 21
Dravet Syndrome
Edwards Syndrome/Trisomy 18
Fragile X Syndrome
Fumarase Deficiency
GLUT1-DS Condition
Glutaric Aciduria Type 1
Goldenhar’s Syndrome
Hunter Syndrome
Hurler-Scheie Syndrome
Hypomyelination
Incomplete Corpus Callosum/Aicardi Syndrome
Inversion Duplication of Chromosome 8
Jacobsen Syndrome/11q Chromosome Deletion
Joubert Syndrome
Kabuki Syndrome
Langer-Gideon Syndrome
Lawrence Moon Biedel Syndrome
Lennox-Gastaut Syndrome
Lesch-Nyhan Syndrome
Lissencephaly
Lowe Syndrome
Mannosidosis
Maple Syrup Urine Disease
Meningitis
Menkes Syndrome
Microcephaly
Mitochondrial Deficiency
Molybdenum Cofactor Deficiency
Mowat-Wilson Syndrome
Mucolipidosis IV
Myotonic Dystrophy (Type 1)
Neonatal Hypoxia
Neonatal Onset Multisystem Inflammatory Disease
Normal Pressure Hydrocephalus
OHDO Syndrome
Opitz Trigonocephaly Syndrome
Ohtahara Syndrome
Ouvrier Syndrome
Pallister-Killian Mosaic Syndrome
Periventricular Leukomalacia
Peroxisome Biogenesis Disorder
Phelan McDermid Syndrome/22q 13 Deletion Syndrome
Phenylketonuria
Polymicrogyria
Pontocerebellar Hypoplasia
Prader-Willi Syndrome
Pyruvate Dehydrogenase Deficiency/Leigh's Disease
Rare Congenital Neurological Syndromes and Conditions
Rasmussen's Disease
Rett Syndrome
Rubinstein-Taybi Syndrome
Schizencephaly
Sensory Integration Disorder/Dysfunction
Smith-Lemli-Opitz Syndrome
Smith-Magenis Syndrome
Sotos Syndrome
Sturge-Weber Syndrome
Subcortical Band Heterotopia
Translocation of Chromosome 2
Translocation Trisomy 5/18
Trichothiodystrophy
Trisomy 10
Trisomy 13
Trisomy 20p
Trisomy 47
Trisomy 4p
Trisomy 9
Tuberous Sclerosis
Turner Syndrome
Urea Cycle Defect
Valproate Embryopathy
Velocardiofacial Syndrome
West Syndrome
Williams Syndrome
Wolf-Hirschhorn Syndrome
X-Linked Adrenoleukodystrophy
Young-Simpson Syndrome
Category 4 PARAPLEGIA and QUADRIPLEGIA
Paraparesis
Spinal Cord Compression
Spinal Cord Infarction
Spinal Damage
Syringomyelia
Tetraplegia
Transverse Myelitis
Category 5 ACQUIRED NEUROLOGICAL CONDITIONS
Acquired Brain Injury
Adhesive Arachnoiditis
Alcoholic Encephalopathy
Alzheimer's Disease
Arachnoiditis
Ascending Polyneuropathy
Astrocytoma
Autonomic Neuropathy Disease
Basal Ganglia Infarction
Benign Meningioma
Brown-Sequard Syndrome
Cauda Equina Lesion
Cerebral Abscess (Cryptococcus)
Cerebral Aneurysm
Cerebral Anoxia
Cerebral Toxoplasmosis
Cerebral Tumour
Cerebrovascular Disease
Chronic Hypoxia
Chronic Inflammatory Demyelination Polyneuropathy (CIDP)
Cortical-Basal Ganglionic Degeneration
Dementia
Developmental/Motor Dyspraxia
Diabetic Autonomic Neuropathy
Diabetic Neuropathic Bladder
Dorsal Pontine Band Syndrome
Encephalitis
Ependymoma
Epilepsy
Focal Cerebral Degeneration
Glioblastoma Multiforme
Glioblastoma of Spine
Hepatic Encephalopathy
Hydrocephalus
Hypoxic Brain Damage
Inoperable Neurogenic Incontinence
Intracerebral Haemorrhage
Korsakoff’s Syndrome
Leuco Posterior Encephalopathy
Lewi Body Disease
Macroencephaly
Malignant Meningioma
Metastatic Carcinoma with Neurological Syndrome
Multiple Systems Atrophy
Myopathy
Nemaline Myopathy
Oligodendroglioma
Pachymeningitis
Picks Disease
Pilocytic Astrocytoma
Poliomyelitis
Polymyoneuropathy
Primary Dystonia (case by case)
Progressive Systemic Sclerosis
Sacral Neuroplexy
Sacral Plexopathy
Schizophrenia (Catatonic)
Spinal Canal Disease
Spinal Chordoma
Spinal Ependymoma
Spinal Sacral Chordoma
Spinal Tumour
Stroke/Cerebrovascular Accident (CVA)
Subarachnoid Haemorrhage
Subdural Haematoma
Vascular Dementia
Category 6 DEGENERATIVE NEUROLOGICAL DISEASES
Alexander Disease
Amyotrophic Lateral Sclerosis
Ataxia Telangiectasia
Cauda Equina Syndrome
Cervical Canal Stenosis
Cervical Myelopathy
Creutzfeldt-Jakob Disease (CJD)
Cytochrome C Oxidase Deficiency
Dejerine-Sottas Disease
Demyelinating Neuropathy
Demyelination of White Matter
Fahr's Disease
Friedreich’s Ataxia
Guillain Barre Syndrome
Huntington Chorea/Disease
Hypoxic Ischaemic Encephalopathy
Idiopathic Axonal Neuropathy
Kugelberg-Welander Syndrome
Machado Joseph Disease
Metachromatic Leukodystrophy
Mitochondrial Myopathy with Encephalopathy
Morquio Syndrome
Motor Neurone Disease
Multiple Sclerosis
Muscular Dystrophy
Myoneural Disorders
Neuroaxonal Dystrophy
Neurofibromatosis NF
Neurogenic Bowel
Niemann-Pick Disease Type C
Pallister-Hall Syndrome
Parkinson Disease
Parkinsonism
PEHO Syndrome (Progressive encephalopathy with oedema, hypsarrhythmia and optic atrophy)
Pelizaeus Merzbacher Disease
Primary Lateral Sclerosis
Progressive Supranuclear Palsy/Steele Richardson Syndrome
Sanfilippo Syndrome
Sarcoidosis of the Brain
Shy-Drager Syndrome
Spinal Cord Syndrome
Spinal Degeneration
Spinal Muscular Atrophy Type 1
Spinal Muscular Atrophy Type 2
Spinocerebellar Degeneration
Stiff-Mans Syndrome
Striato-Nigral Degeneration
Vascular Myelopathy
Wallerian Degeneration of White Matter
Wilson's Disease
Category 7 BLADDER (BOWEL) INNERVATION DISORDERS
Atonic Bladder/Hypotonic Bladder
Bladder Exstrophy
Bladder Innervation Urgency
Cloacal Exstrophy
Cystocele (not suitable for surgery)
Dysfunctional Voiding
Dystonic Bladder
Ectopia Vesica
Hirschsprung's Disease
Linear Sebaceous Nevus Genetic
Myasthenia Gravis
Neurogenic Bladder
Neuronal Intestinal Dysplasia
Neuropathic Bladder
Post Bladder Surgery
Prostatectomy with nerve removal
Prune Belly Syndrome
Pudendal Nerve Palsy
Radical Prostatectomy
Schmidli Autonomic Neuropathy
Slow Transit Constipation
Smooth Muscle Myopathy
Sphincter Deficiency
Spinal Stenosis
Part 2 – Eligible other condition
Category 8 OTHER
Anal Carcinoma
Anal Fistula
Anorectal Malformation
Anterior Prolapse
Bilateral Nephrostomy Tubes
Bladder Cancer
Bladder Instability
Bladder Muscle Dysfunction
Bladder Neck Dysfunction
Bladder Neck Fibrosis
Bladder Prolapse
Bowel Cancer
Bowel Prolapse
Cervical Cancer
Chronic Urinary Retention
Congenital Epispadias
Detrusor Instability
Detrusor Overactivity
Enterocutaneous Fistula
Faecal Incontinence Post-Colectomy
Hypertonic Bladder
Imperforate Anus
Irradiated Rectum/Radiation Proctitis
Metastatic Ovarian Carcinoma
Post Ileorectal Anastomosis
Post Ileal J Pouch Anastomosis
Posterior Urethral Valve Syndrome
Prostate Cancer
Prostate Disease
Rectal Prolapse
Rectal Ulcer Syndrome
Severe Ulcerative Proctitis
Spastic Bladder
Transurethral Resection of the Prostate (TURP)
Urethral Stenosis
Urinary Fistula
Uterine Cancer
Uterine Prolapse
Vaginal Prolapse
Vesico-Vaginal Fistula
Vulva Cancer
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0